SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-038304
Filing Date
2023-02-14
Accepted
2023-02-14 12:57:59
Documents
2
Group Members
NEIL SHAHRESTANI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d438281dsc13ga.htm SC 13G/A 61935
2 EX-99.1 d438281dex991.htm EX-99.1 3631
  Complete submission text file 0001193125-23-038304.txt   67224
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Subject) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88629 | Film No.: 23626008
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201
Business Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201 214-364-2883
Ikarian Capital, LLC (Filed by) CIK: 0001778253 (see all company filings)

IRS No.: 473466768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A